Based on the presented results, a single or double biomarker combination (for example, presepsin and IL-6) for diagnostic and prognostic assessment appears to be useful in patients with severe sepsis or septic shock being treated on a medical ICU. This evidence concerns the gene IL6 and Sepsis.